EWTX logo

Edgewise Therapeutics (EWTX) Company Overview

Profile

Full Name:

Edgewise Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 26, 2021

Indexes:

Not included

Description:

Edgewise Therapeutics (EWTX) is a biotechnology company focused on developing innovative treatments for muscle disorders. They use advanced technology to create therapies that target specific muscle conditions, aiming to improve patients' quality of life and address unmet medical needs in the field of rare diseases.

Events Calendar

Earnings

Next earnings date:

Mar 3, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 3, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 22, 25 Stifel
Hold
Dec 17, 24 Evercore ISI Group
Outperform
Nov 27, 24 Truist Securities
Buy
Nov 22, 24 Evercore ISI Group
Outperform
Nov 8, 24 Wedbush
Outperform
Oct 11, 24 Piper Sandler
Overweight
Sep 20, 24 RBC Capital
Outperform
Sep 19, 24 Truist Securities
Buy
Sep 17, 24 RBC Capital
Outperform
Aug 16, 24 Wedbush
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Edgewise Therapeutics?
  • Does Edgewise Therapeutics pay dividends?
  • What sector is Edgewise Therapeutics in?
  • What industry is Edgewise Therapeutics in?
  • What country is Edgewise Therapeutics based in?
  • When did Edgewise Therapeutics go public?
  • Is Edgewise Therapeutics in the S&P 500?
  • Is Edgewise Therapeutics in the NASDAQ 100?
  • Is Edgewise Therapeutics in the Dow Jones?
  • When was Edgewise Therapeutics's last earnings report?
  • When does Edgewise Therapeutics report earnings?
  • Should I buy Edgewise Therapeutics stock now?

What is the ticker symbol for Edgewise Therapeutics?

The ticker symbol for Edgewise Therapeutics is NASDAQ:EWTX

Does Edgewise Therapeutics pay dividends?

No, Edgewise Therapeutics does not pay dividends

What sector is Edgewise Therapeutics in?

Edgewise Therapeutics is in the Healthcare sector

What industry is Edgewise Therapeutics in?

Edgewise Therapeutics is in the Biotechnology industry

What country is Edgewise Therapeutics based in?

Edgewise Therapeutics is headquartered in United States

When did Edgewise Therapeutics go public?

Edgewise Therapeutics's initial public offering (IPO) was on March 26, 2021

Is Edgewise Therapeutics in the S&P 500?

No, Edgewise Therapeutics is not included in the S&P 500 index

Is Edgewise Therapeutics in the NASDAQ 100?

No, Edgewise Therapeutics is not included in the NASDAQ 100 index

Is Edgewise Therapeutics in the Dow Jones?

No, Edgewise Therapeutics is not included in the Dow Jones index

When was Edgewise Therapeutics's last earnings report?

Edgewise Therapeutics's most recent earnings report was on Nov 7, 2024

When does Edgewise Therapeutics report earnings?

The next expected earnings date for Edgewise Therapeutics is Mar 3, 2025

Should I buy Edgewise Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions